10:34AM ET 1/11/2021 MT NewswiresExicure (XCUR) said on Monday the US Food and Drug Administration has granted Fast Track designations for its product candidate, cavrotolimod, for the...
3:23AM ET 12/22/2020 MT NewswiresExicure (XCUR) on Monday filed a registration statement covering the potential sale of up to $150 million in securities. The securities, which may be...
11:27AM ET 12/21/2020 MT NewswiresExicure (XCUR) said Monday that it has received two US patents as well as patent allowance covering cavrotolimod, which is being developed as a potential...
8:29AM ET 12/18/2020 MT Newswires(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...